Boostrix Tdap
Selected indexed studies
- Erroneous statement. (Reprod Toxicol, 2024) [PMID:38823463]
- Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents. (Vaccine, 2024) [PMID:39226786]
- Adult immunization. (Med Lett Drugs Ther, 2022) [PMID:36206162]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Erroneous statement. (2024) pubmed
- Adult immunization. (2022) pubmed
- Vaccines for travelers. (2018) pubmed
- Adacel and Boostrix: Tdap vaccines for adolescents and adults. (2006) pubmed
- Adult immunization. (2018) pubmed
- Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents. (2024) pubmed
- Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine. (2022) pubmed
- Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization. (2012) pubmed
- Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US. (2009) pubmed
- Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix(®)): a guide to its use as a single-dose booster immunization against pertussis. (2013) pubmed